Genetic Prostate Cancer
A genetic test that looks for variants in 14 genes associated with inherited prostate cancer risk.
Results usually available within 4-6 weeks after the laboratory receives your sample
What does it check?
- BRCA1, BRCA2, ATM genes
- HOXB13 (hereditary prostate cancer risk)
- Mismatch repair genes (MLH1, MSH2, MSH6, PMS2)
- CHEK2, PALB2, NBN, RAD51D genes
Who may benefit?
Men with a family history of early or aggressive prostate cancer, or families with known BRCA mutations or Lynch syndrome.
Genetic Prostate Cancer
SMITHS
Medical Group
What is it?
A genetic test that looks for variants in 14 genes associated with inherited prostate cancer risk.
Who may benefit?
Men with a family history of early or aggressive prostate cancer, or families with known BRCA mutations or Lynch syndrome.
Comprehensive gene panel
BRCA1, BRCA2, ATM genes
HOXB13 (hereditary prostate cancer risk)
Mismatch repair genes (MLH1, MSH2, MSH6, PMS2)
CHEK2, PALB2, NBN, RAD51D genes
Important information
Results assist in tailoring PSA screening frequency, assessing aggressive disease risk, and informing treatment approaches if prostate cancer is diagnosed.